Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients.

Heudel, P; Favier, B; Assaad, S; Zrounba, P; Blay, J-Y

Heudel, P; Favier, B; Assaad, S; Zrounba, P; Blay, J-Y.

Afiliação

Heudel P; Department of Medical Oncology, Centre Léon Bérard Cancer Center, Lyon, France.
Favier B; Department of Pharmaceutical Oncology, Centre Léon Bérard Cancer Center, Lyon, France.
Assaad S; Department of Medical Oncology, Centre Léon Bérard Cancer Center, Lyon, France.
Zrounba P; Department of Surgery, Centre Léon Bérard Cancer Center, Lyon, France.
Blay JY; Department of Medical Oncology, Centre Léon Bérard Cancer Center, Lyon, France; Lyon East Faculty of Medicine, Université Claude Bernard Lyon 1, Lyon, France; President, Unicancer, Paris, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.

Ann Oncol ; 32(11): 1443-1444, 2021 11.

Article em En | MEDLINE | ID: mdl-34333128

Assuntos

COVID-19; Neoplasias; Vacinas contra COVID-19; Humanos; Neoplasias/tratamento farmacológico; SARS-CoV-2; Vacinação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Limite: Humans Idioma: En Revista: Ann Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google